Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD) [PDF]
, 2004 Wajeh Y. Qunibi
openalex +1 more source
Safety and Phosphate‐Binding Capacity of Oxylanthanum Carbonate in Healthy Volunteers
Clinical and Translational ScienceDespite the widespread use of currently available serum phosphate management options, elevated serum phosphate is common in patients with end‐stage kidney disease on dialysis.
Pablo E. Pergola +7 more
doaj +1 more source
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword [PDF]
, 2017 The Kidney Disease: Improving Global Outcomes (KDIGO) 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD) represents a selective update of the ...
Wheeler, DC, Winkelmayer, WC
core
Acute tumoral calcinosis due to severe hyperphosphatemia in a maintenance hemodialysis patient [PDF]
, 2016 Keizo Nishime, Hiroki Takahashi
openalex +1 more source
Phosphate Transporter Regulator That Prevents Abnormal Hyperphosphatemia. [PDF]
, 2021 Sumire Sasaki +15 more
openalex +1 more source
Factors associated with delayed arteriovenous fistula maturation in chronic kidney disease patients [PDF]
, 2015 There has been an increasing trend of end stage renal disease patients requiring haemodialysis treatment worldwide. Vascular access remains the key component of haemodialysis treatment, unfortunately, the maintenance of this access remains a challenging ...
Huey Tean, Kok
core
Gambaran Kadar Fosfat Anorganik Pada Serum Pada Pasien Penyakit Ginjal Kronik Stadium 5 Nondialisis [PDF]
, 2016 : Chronic kidney disease is a public health problem in Indonesia. Hyperphosphatemia is a metabolic disorded in patients with chronic kidney disease in which the phosphate concentration increased more than 5 mg/dL.
Rambert, G. (Glady) +2 more
core
Benefícios dos Ativadores Seletivos dos Recetores de Vitamina D em Doentes Transplantados Renais [PDF]
, 2015 Severe chronic kidney disease may lead to disturbances, such as hyperphosphatemia, increased secretion of fibroblast growth factor -23 (FGF -23) and vitamin D deficiency.
Aires, I +9 more
core
2025 ACVIM Forum Research Abstract Program
Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley +1 more source
Parathyroid hormone-related peptide and vitamin D in phosphocalcic metabolism for dromedary camel [PDF]
, 2011 In mammals, phosphocalcic and bone metabolisms are mainly regulated by parathyroïd hormone, parathyroïd hormone-related peptide (PTHrP) and 1[alpha],25-dihydroxyvitamin D or calcitriol. In camels, circulating levels of calcitriol are 10 times higher than
El Khasmi, Mohammed, Faye, Bernard
core